In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kipchu Tshering, Mir Misbahuddin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Saila:Bangabandhu Sheikh Mujib Medical University Journal
Gaiak:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Sarrera elektronikoa:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak